X

Xtant Medical Holdings Inc
AMEX:XTNT

Watchlist Manager
Xtant Medical Holdings Inc
AMEX:XTNT
Watchlist
Price: 0.4112 USD -4.9% Market Closed
Market Cap: $57.7m

Wall St Price Targets

XTNT Price Targets Summary
Xtant Medical Holdings Inc

Wall Street analysts forecast XTNT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XTNT is 1.258 USD with a low forecast of 1.01 USD and a high forecast of 1.575 USD.

Lowest Forecast
Price Target
1.01 USD
146% Upside
Average Forecast
Price Target
1.258 USD
206% Upside
Highest Forecast
Price Target
1.575 USD
283% Upside
Xtant Medical Holdings Inc Competitors:
Price Targets
RVTY
Revvity Inc
4% Upside
1INN
innoscripta SE
189% Upside
VRTX
Vertex Pharmaceuticals Inc
18% Upside

Revenue
Forecast

11% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 3%.

Gross Profit
Forecast

11% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
11% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 6 years is 5%.

Operating Income
Forecast

N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate for Operating Income over the next 6 years is 36%.

Pre-Tax Income
Forecast

N/A
Past Growth
-27% / Year
Estimated Growth
Estimates Accuracy
20%
Average Beat
N/A
Past Growth
-27% / Year
Estimated Growth
Estimates Accuracy
20%
Average Beat

The compound annual growth rate for Pre-Tax Income over the next 3 years is -27%.

Net Income
Forecast

N/A
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

The compound annual growth rate for Net Income over the next 6 years is 42%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is XTNT's stock price target?
Price Target
1.258 USD

According to Wall Street analysts, the average 1-year price target for XTNT is 1.258 USD with a low forecast of 1.01 USD and a high forecast of 1.575 USD.

What is the Revenue forecast for Xtant Medical Holdings Inc?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 3%.

What is the Gross Profit forecast for Xtant Medical Holdings Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 6 years is 5%.

What is the Operating Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
36%

The compound annual growth rate for Operating Income over the next 6 years is 36%.

What is the Pre-Tax Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
-27%

The compound annual growth rate for Pre-Tax Income over the next 3 years is -27%.

What is the Net Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
42%

The compound annual growth rate for Net Income over the next 6 years is 42%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett